CytoDyn Leadership Change
CytoDyn appointed Robert E. Hoffman as Chief Executive Officer, effective October 20, 2026, succeeding Dr. Jacob Lalezari. Dr. Lalezari resigned from the CEO role but will remain with the company as Head of Research and Translational Sciences. Mr. Hoffman, who previously served as the company's CFO, will also continue to serve as the principal accounting officer.